OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Reply: Is postural tachycardia syndrome a psychogenic disorder?; Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome; Patients with POTS fear that data o	329
The axon initial segment as a source of neuropathic pain	318
De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features	280
Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease	265
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum	169
Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins	160
Thalamostriatal disconnection underpins long-term seizure freedom in frontal lobe epilepsy surgery	159
Methodological drawbacks in the alleged association between foetal sonographic anomalies and autism	156
Correction to: Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders	156
The efficacy and deficiency of contemporary treatment for spinal cord arteriovenous shunts	150
Proust and his neurologists: the challenge of functional disorders	144
‘Seeding’ the idea of early diagnostics in synucleinopathies	142
Genetically identical twin-pair difference models support the amyloid cascade hypothesis	140
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease	140
Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations	135
From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis	132
3T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulation	132
Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism	131
The inferior fronto-occipital fasciculus: bridging phylogeny, ontogeny and functional anatomy	125
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures	122
Lesion correlates of impaired acoustic-phonetic perception after unilateral left hemisphere stroke	121
Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder	120
Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation	119
Speech and language markers of neurodegeneration: a call for global equity	118
Dysfunction of the magnocellular subdivision of the visual thalamus in developmental dyslexia	118

Clinical and genetic spectrum of 355 Chinese children with epilepsy: a trio-sequencing-based study	117
Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease	115
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes	111
Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline	110
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups	109
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1	108
Deep brain stimulation: a tale of two targets … and closing the loop	108
18F-MK-6240 tau-PET in genetic frontotemporal dementia	108
Brain repair mechanisms after cell therapy for stroke	104
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults	101
Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation	101
Source-sink connectivity: a novel interictal EEG marker for seizure localization	100
Biallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy	100
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development	98
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression	98
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine	97
ActivatingRAC1variants in the switch II region cause a developmental syndrome and alter neuronal morphology	96
The use of optical coherence tomography in neurology: a review	95
‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy	89
Correction to: New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy	86
The vascular contribution of apolipoprotein E to Alzheimer’s disease	86
Multicentre analysis of seizure outcome predicted by removal of high-frequency oscillations	85
Genome-wide association study of neuropathological features in Lewy body disease	84
Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy	83
The neuroethics of disorders of consciousness: a brief history of evolving ideas	83
Hitching a ride on exosomes: a new approach for the delivery of siRNA-mediated therapies	82
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence	80
A sensory neuron-specific long non-coding RNA reduces neuropathic pain by rescuing KCNN1 expression	79
Loss-of-function variants inMYCBP2cause neurobehavioural phenotypes and corpus callosum defects	79
Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy	78
How COVID-19 affects microvessels in the brain	78
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease	77
Defective lipid signalling caused by mutations inPIK3C2Bunderlies focal epilepsy	76
Novel insight into TRPV1-induced mitochondrial dysfunction in neuropathic pain	74
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults	74
Clinical features and prognostic factors in adults with brain abscess	74
Long-term neuropsychological trajectories in children with epilepsy: does surgery halt decline?	74
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration	73
Reply: From early limbic inflammation to long COVID sequelae	72
The cost to see the Wizard: buy-ins and trade-offs in neurological rehabilitation	72
Extra-cranial cholinergic lesions in dementia with Lewy bodies	71
The three deceits of bureaucracy	71
Evolutionary perspectives on mRNA signatures of neurodegeneration-related brain remodelling	71
Demystifying interictal discharges and seizure initiation in focal epilepsy	70
Biallelic null variants in PNPLA8 cause microcephaly by reducing the number of basal radial glia	70
Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies	70